GeoVax Labs, Inc. (GOVX)
NASDAQ: GOVX · Real-Time Price · USD
2.950
+0.250 (9.26%)
At close: Sep 20, 2024, 4:00 PM
2.900
-0.050 (-1.69%)
After-hours: Sep 20, 2024, 4:43 PM EDT
GeoVax Labs Income Statement
Financials in millions USD. Fiscal year is January - December.
Millions USD. Fiscal year is Jan - Dec.
| TTM
| FY 2023 | FY 2022 | FY 2021 | FY 2020 | FY 2019 |
| Jun '24 Jun 30, 2024 | Dec '23 Dec 31, 2023 | Dec '22 Dec 31, 2022 | Dec '21 Dec 31, 2021 | Dec '20 Dec 31, 2020 | Dec '19 Dec 31, 2019 |
| Revenue | 0.3 | - | 0.08 | 0.39 | 1.82 | 1.18 | |
| Revenue Growth (YoY) | - | - | -78.85% | -78.86% | 55.09% | 22.08% | |
| Cost of Revenue | 21.88 | 20.72 | 9.12 | 15.55 | 2.44 | 1.91 | |
| Gross Profit | -21.58 | -20.72 | -9.04 | -15.17 | -0.62 | -0.73 | |
| Selling, General & Admin | 5.66 | 6.02 | 4.99 | 3.58 | 2.2 | 1.64 | |
| Operating Expenses | 5.66 | 6.02 | 4.99 | 3.58 | 2.2 | 1.64 | |
| Operating Income | -27.24 | -26.74 | -14.03 | -18.75 | -2.82 | -2.37 | |
| Interest Expense | -0.01 | - | - | -0 | -0.14 | -0 | |
| Interest & Investment Income | 0.33 | 0.78 | 0.01 | 0 | 0 | 0.01 | |
| EBT Excluding Unusual Items | -26.92 | -25.97 | -14.02 | -18.74 | -2.96 | -2.37 | |
| Other Unusual Items | - | - | - | 0.17 | - | - | |
| Pretax Income | -26.92 | -25.97 | -14.02 | -18.57 | -2.96 | -2.37 | |
| Net Income | -26.92 | -25.97 | -14.02 | -18.57 | -2.96 | -2.37 | |
| Net Income to Common | -26.92 | -25.97 | -14.02 | -18.57 | -2.96 | -2.37 | |
| Shares Outstanding (Basic) | 2 | 2 | 1 | 0 | 0 | - | |
| Shares Outstanding (Diluted) | 2 | 2 | 1 | 0 | 0 | - | |
| Shares Change (YoY) | 25.27% | 60.60% | 178.25% | 340.80% | - | - | |
| EPS (Basic) | -12.79 | -14.29 | -12.39 | -45.67 | -32.06 | - | |
| EPS (Diluted) | -12.79 | -14.29 | -12.39 | -45.67 | -32.06 | - | |
| Free Cash Flow | -23.02 | -25.22 | -19.16 | -11.24 | -2.91 | -1.41 | |
| Free Cash Flow Per Share | -10.94 | -13.88 | -16.94 | -27.65 | -31.51 | - | |
| Gross Margin | - | - | - | - | -34.04% | -62.49% | |
| Operating Margin | -9059.16% | - | -17207.47% | -4862.72% | -154.46% | -201.76% | |
| Profit Margin | -8951.60% | - | -17198.35% | -4817.19% | -162.21% | -201.60% | |
| Free Cash Flow Margin | -7657.23% | - | -23507.18% | -2916.76% | -159.42% | -119.58% | |
| EBITDA | -27.16 | -26.67 | -13.97 | -18.71 | -2.8 | -2.36 | |
| EBITDA Margin | - | - | - | - | -153.38% | -201.05% | |
| D&A For EBITDA | 0.08 | 0.07 | 0.06 | 0.04 | 0.02 | 0.01 | |
| EBIT | -27.24 | -26.74 | -14.03 | -18.75 | -2.82 | -2.37 | |
| EBIT Margin | - | - | - | - | -154.46% | -201.76% | |
Source: S&P Capital IQ. Standard template.
Financial Sources.